Inflammation is essential for host defense but can cause tissue damage and organ failure if unchecked. How the inflammation is resolved remains elusive. Here we report that the transcription factor Miz1 was required for terminating lipopolysaccharide (LPS)-induced inflammation. Genetic disruption of the Miz1 POZ domain, which is essential for the transactivation or repression activity of Miz1, resulted in hyperinflammation, lung injury and greater mortality in LPS-treated mice but a lower bacterial load and mortality in mice with Pseudomonas aeruginosa pneumonia. Loss of the Miz1 POZ domain prolonged the expression of proinflammatory cytokines. After stimulation, Miz1 was phosphorylated at Ser178, which was required for recruitment of the histone deacetylase HDAC1 to repress transcription of the gene encoding C/EBP-d, an amplifier of inflammation. Our data provide a long-sought mechanism underlying the resolution of LPS-induced inflammation.
Inflammation is required for the activation of innate and adaptive immunity, which is essential for host defense against invading pathogens such as viruses and bacteria 1, 2 . The inflammatory response must be resolved after the pathogens are cleared, because unchecked inflammation can cause tissue damage and organ failure in the host. However, the mechanism that controls resolution of the inflammatory response is incompletely understood.
Lipopolysaccharide (LPS; also known as endotoxin) is a structural component of the outer membranes of Gram-negative bacteria and is a potent inducer of inflammation 3 . LPS binds to and signals through Toll-like receptor 4 (TLR4), which leads to the rapid release of proinflammatory cytokines, such as tumor-necrosis factor (TNF), and chemokines. Subsequently, TNF acts through its membrane receptor 1 complex I (refs. [4] [5] [6] to activate multiple downstream effectors, such as the mitogen-activated protein (MAP) kinases Jnk, p38 and Erk and the transcription factor NF-κB, to further induce the production of proinflammatory cytokines and chemokines, including interleukin 6 (IL-6), IL-1β and MCP-1, thereby amplifying the inflammatory response 7, 8 .
A complex transcriptional regulatory network is involved in the control of the LPS-induced inflammatory response 9, 10 . The expression of a large number of LPS-induced genes is controlled by a transcriptional regulatory circuit composed of the following three transcription factors: NF-κB (the initiator), C/EBP-δ (the amplifier) and ATF-3 (the attenuator) 9 . In this circuit, immediate activation of NF-κB triggers early induction of LPS-responsive genes. Concomitantly, NF-κB binds to the promoter of the gene encoding C/EBP-δ (Cebpd) and activates its transcription. C/EBP-δ in turn binds to the promoters of LPS-induced target genes, including those encoding proinflammatory cytokines, and acts together with NF-κB to stimulate maximal transcription of many genes targeted by LPS 9 , thereby contributing to the amplification and persistence of the inflammation. C/EBP-δ also autoinduces transcription of its own gene, Cebpd 11 . In parallel, NF-κB induces transcription of the gene encoding ATF-3. ATF-3 subsequently binds to the promoter of Cebpd and suppresses its transcription, thereby attenuating the inflammatory response 9 . However, in the absence of ATF-3, the transcription of Cebpd still decreases quickly, as it does in wild-type control cells 11 . Thus, other mechanism(s) must exist to repress Cebpd transcription to switch off the amplification, thereby resolving the inflammatory response.
The transcription factor Miz1 was first identified as a protein that interacts with the transcription factor c-Myc 12, 13 ; it has an aminoterminal POZ (poxvirus and zinc-finger) domain that is required for its transcriptional activity, and 13 zinc fingers at its carboxyl terminus 12 . Miz1 serves a critical role in regulating proliferation, differentiation, cell-cycle progression and apoptosis through the transcriptional activation and repression of its target genes 11, 12, 14, 15 . Miz1 in the cytoplasm 12, [16] [17] [18] [19] suppresses LPS-and TNF-induced inflammatory responses by specifically interfering with Jnk activation, independently of its transcriptional activity [16] [17] [18] 20 . It is not known A r t i c l e s whether nuclear Miz1 has a role in regulating inflammation and, if so, what the mechanism is. Here we report that nuclear Miz1 was required for the termination of LPS-induced inflammation through its repression of Cebpd transcription and thereby constrained acute lung injury and diminished mortality in mice. Thus, Miz1 provides a critical transcriptional checkpoint that prevents excessive inflammatory responses and tissue damage in the host.
RESULTS

Miz1 suppresses lung inflammation and injury
To study the role of nuclear Miz1 in lung inflammation, we disrupted sequence encoding the Miz1 POZ domain in the gene encoding Miz1 (Zbtb17; called 'Miz1' here) in the lungs by intratracheal administration of adenovirus encoding Cre recombinase (Ad-Cre) into mice in which exons encoding the Miz1 POZ domain were flanked by loxP sites (Miz1(POZ) fl/fl ) [21] [22] [23] . Allele-specific genomic PCR and RT-PCR analysis 30 d later showed deletion of the Miz1 POZ domain (Miz1(∆POZ)) in the lungs of Miz1(POZ) fl/fl mice treated with Ad-Cre (Miz1 ∆POZ−lung mice) but not in control Miz1(POZ) fl/fl mice treated with empty adenovirus vector (Ad-null) or in wild-type mice ( Fig. 1a and Supplementary Fig. 1a ). Immunoblot analysis of whole-lung homogenates showed a lower molecular mass for Miz1 in Miz1 ∆POZ−lung mice that was consistent with deletion of the POZ domain (Supplementary Fig. 1b) . We detected truncated Miz1 protein by immunoblot analysis of primary alveolar epithelial type II (ATII cells) cells isolated from Miz1 ∆POZ−lung mice (Fig. 1b) . In contrast, there was no deletion of the Miz1 POZ domain in hematopoietic cell-derived cells cells under this condition, as analyzed by semiquantitative or real-time RT-PCR ( Supplementary Fig. 1c,d ). This result was consistent with published reports that intratracheal infection with Ad-Cre results in efficient recombination in the alveolar epithelium 21, [23] [24] [25] .
To determine whether nuclear Miz1 regulates lung inflammation, we used a mouse model of intratracheal LPS-induced inflammation and acute lung injury 26 . We infected wild-type and (Fig. 1c) . Inflammatory cell numbers and protein concentrations were much higher in the bronchoalveolar lavage (BAL) fluid of Miz1 ∆POZ−lung mice than in that of Ad-null-infected Miz1(POZ) fl/fl mice or wild-type mice ( Fig. 1d and Supplementary  Fig. 1e,f) . We found that the airway epithelium was intact in both AdCre-infected Miz1(POZ) fl/fl mice and Ad-null-infected Miz1(POZ) fl/fl mice (before LPS challenge) when we analyzed the permeability of the alveolar capillary membrane by intravenously injecting Evans blue dye ( Supplementary Fig. 1g,h ) or fluorescein isothiocyanate-labeled dextran (4 kilodaltons; Supplementary Fig. 1i ) or by lung water content (Supplementary Fig. 1j ). This suggested that the hyperinflammatory state of LPS-treated Miz1 ∆POZ−lung mice was not due to leakage of the airway epithelium induced by loss of the Miz1 POZ domain. The resolution of lung inflammation and injury was considerably delayed in Miz1 ∆POZ−lung mice (Fig. 1e) . Neither Ad-null-treated Miz1(POZ) fl/fl mice nor Ad-Cre-treated Miz1(POZ) fl/fl mice died after treatment with a low dose of LPS (6 mg/kg; Supplementary  Fig. 1k ). However, 50% of Ad-Cre-treated Miz1(POZ) fl/fl mice died within 4 d of treatment with a high dose of LPS (12 mg/kg), whereas all Ad-null-treated mice survived under the same conditions (Fig. 1f) . Thus, deletion of the Miz1 POZ domain in the lung rendered mice highly susceptible to LPS-induced inflammation, acute lung injury and mortality in vivo.
To demonstrate that disruption of the Miz1 POZ domain in lung epithelial cells was sufficient to augment LPS-induced inflammation and lung injury, we infected Miz1(POZ) fl/fl mice intratracheally with an adenovirus that targets Cre recombinase specifically to lung epithelial cells (Ad-SPC-Cre) 27 . We found deletion of the Miz1 POZ domain in ATII cells, but not in cells derived from the hematopoietic compartment, in lungs from Miz1(POZ) fl/fl mice treated intratracheally with Ad-SPC-Cre (Supplementary Fig. 1c,d ). We also found that Miz1(POZ) fl/fl mice infected with Ad-SPC-Cre had augmented LPSinduced lung inflammation and injury similar to that of Miz1(POZ) fl/fl mice infected with Ad-Cre (Fig. 1g) . Thus, Miz1 in lung epithelial cells had a critical role in LPS-induced lung inflammation and injury. However, Miz1 in other cell types, such as cells derived from the hematopoietic compartment, may also have an important role in LPS-induced inflammation. Using the approach of bone marrow transplantation, we found that lethally irradiated wild-type recipient mice reconstituted with Miz1(POZ) fl/fl bone marrow cells transduced with Cre-expressing lentivirus ( Supplementary Fig. 1l,m) had more lung inflammation and more-severe tissue damage induced by intratracheal LPS than did those reconstituted with Miz1(POZ) fl/fl bone marrow cells transduced with null lentivirus ( Supplementary  Fig. 1n ). Thus, Miz1 in hematopoietic cells was also important in regulating lung inflammation.
Miz1 inhibits proinflammatory cytokine production LPS induces rapid production and release of proinflammatory cytokines and chemokines, which are sufficient to induce lung inflammation and acute injury in mice and humans 28 . When we treated Ad-Cre-or Ad-null-infected Miz1(POZ) fl/fl mice with LPS for 8 h, we found significantly more production of TNF, IL-6, IL-1β and MCP-1 in Miz1 ∆POZ−lung mice than in Ad-null-infected Miz1(POZ) fl/fl mice ( Fig. 2a-d) . In contrast, the concentration of the anti-inflammatory cytokine IL-10 was not affected by loss of the Miz1 POZ domain (Supplementary Fig. 2a) . Thus, the hypersensitivity of Miz1 ∆POZ−lung mice to LPS was associated with a greater abundance of proinflammatory cytokines and chemokines.
To determine whether Miz1 regulates the inflammatory response in ATII cells, which are critical participants in the initiation and amplification of lung inflammation 29 , we isolated primary ATII cells from Miz1(POZ) fl/fl mice, infected the cells with Ad-Cre or Ad-null and then left them untreated or treated them with TNF or LPS. Immunoblot analysis showed that cells infected with Ad-Cre, but not those infected with Ad-null, expressed the truncated Miz1 protein ( Supplementary  Fig. 2b) . TNF-or LPS-induced production of IL-6, IL-1β and MCP-1 was significantly greater in Ad-Cre-treated ATII cells from Miz1(POZ) fl/fl mice than in their Ad-null-treated counterparts (Fig. 2e) . We established mouse type II-like lung epithelial (MLE-12) cells in which endogenous Miz1 was stably knocked down by short hairpin RNA (shRNA) specific for Miz1 (Supplementary Fig. 2c ), along 
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A r t i c l e s with transfection for stable expression of similar amounts of wildtype Miz1 or Miz1(∆POZ), each containing silent mutations in their encoding sequences that make them resistant to Miz1-specific shRNA (MLE-12-Miz1(WT) or MLE-12-Miz1(∆POZ) cells, respectively; Supplementary Fig. 2d) . TNF-or LPS-induced production of IL-6, IL-1β and MCP-1 was significantly greater in MLE-12-Miz1(∆POZ) cells than in MLE-12-Miz1(WT) cells (Fig. 2f) . The effect of loss of the Miz1 POZ domain was not due to a potential dominant-negative effect of this deletion, as knockdown of Miz1(∆POZ) (which results in loss of both nuclear and cytoplasmic functions of Miz1) further augmented TNF-induced IL-6 production ( Supplementary Fig. 2e ). Thus, nuclear Miz1 suppressed the LPS-or TNF-induced production of proinflammatory cytokines and chemokines in vivo and in vitro. Loss of the Miz1 POZ domain did not affect the inflammatory response induced by the TLR3 agonist poly(I:C) ( Supplementary Fig. 2f ), which suggested that Miz1 may specifically regulate inflammation mediated by TLR4 and TNF membrane receptor complex I.
Suppression of inflammation in pneumonia by Miz1
We sought to determine whether the augmentation of inflammation resulting from loss of the Miz1 POZ domain would protect mice against bacterial infection. We inoculated mice intranasally with Pseudomonas aeruginosa, a Gram-negative bacterium, and found more production of proinflammatory cytokines and chemokines (Fig. 3a) and a lower bacterial load (Fig. 3b) in the lungs of Miz1 ∆POZ−lung mice than in those of Ad-null-infected Miz1(POZ) fl/fl mice. Accordingly, Miz1 ∆POZ−lung mice had lower mortality (mice that did not die within 4 d recovered and survived; Fig. 3c ), consistent with published reports showing that deficiency in the innate immune response protects the host from a sterile challenge (LPS) while sensitizing them to infection with live bacteria, or vice versa [30] [31] [32] [33] [34] [35] [36] .
Nuclear Miz1 does not affect TNF-induced cell death or growth
We determined whether the hypersensitivity of Miz1 ∆POZ−lung mice to LPS could have been the result of altered apoptosis or proliferation of the lung epithelial cells. TUNEL cell-death assays showed a similar percentage of apoptotic cells in the lungs of Ad-null-infected Miz1(POZ) fl/fl mice and Miz1 ∆POZ−lung mice ( Supplementary  Fig. 3a) . Apoptotic cell-death assays showed no substantial difference between TNF-or LPS-treated primary ATII cells lacking the Miz1 POZ domain and similarly treated ATII cells expressing wild-type Miz1 in their apoptosis (Supplementary Fig. 3b ). We obtained similar results with stable MLE-12-Miz1(∆POZ) and MLE-12-Miz1(WT) cells (Supplementary Fig. 3c ). Furthermore, there was no substantial difference between MLE-12-Miz1(∆POZ) and MLE-12-Miz1(WT) cells in their proliferation, either when left unstimulated or after stimulation with TNF ( Supplementary Fig. 3d ). These data were consistent with published reports showing that Miz1 regulates apoptosis and proliferation in a stimulus-and cell type-dependent manner 11, 14, 17, 37 . Thus, the augmented inflammatory response in LPS-treated Miz1 ∆POZ−lung mice was not caused by deregulation of the apoptosis or proliferation of epithelial cells.
Nuclear Miz1 does not regulate MAP kinases or NF-kB
We determined whether loss of the Miz1 POZ domain augmented activation of MAP kinases or NF-κB. We examined lysates of lungs Fig. 3e ), consistent with published data 17 . We obtained similar results with TNF-or LPS-treated MLE-12-Miz1(WT) and MLE-12-Miz1(∆POZ) cells (Supplementary Fig. 3f-h) . Thus, the hypersusceptibility of Miz1 ∆POZ−lung mice to LPS was not caused by an alteration in the activation of MAP kinases or NF-κB.
Nuclear Miz1 terminates C/EBP-d expression
We assessed the effect of loss of the Miz1 POZ domain on expression of C/EBP transcription factors, which are reported to be critical for regulation of the inflammatory response 9, 38 . The abundance of C/EBP-δ protein and mRNA was greater in Ad-null-infected Miz1(POZ) fl/fl mice challenged with LPS than in their counterparts not treated with LPS (Fig. 4a) , consistent with published reports 38 . The expression of C/EBP-δ protein and mRNA, but not of C/EBP-α or C/EBP-β protein or mRNA, was much higher in Miz1 ∆POZ−lung mice than in their Ad-null-infected Miz1(POZ) fl/fl counterparts, and this was further augmented by treatment with LPS (Fig. 4a) . Loss of the Miz1 POZ domain also resulted in a greater abundance of C/EBP-δ protein and/ or mRNA in primary lung ATII cells (Fig. 4b,c) and stable MLE-12 cells (Fig. 4d,e) without stimulation and after stimulation with TNF or LPS. Notably, the LPS-induced increase in the abundance of C/EBP-δ and IL-6 mRNA in MLE-12-Miz1(∆POZ) cells was of significantly longer duration than that in MLE-12-Miz1(WT) cells (Fig. 4f,g ). Thus, nuclear Miz1 had a critical role in the transcriptional termination of genes targeted by LPS in the late phase of inflammation.
Miz1 suppresses inflammation by repressing Cebpd
We determined whether the augmented production of proinflammatory cytokines caused by loss of the Miz1 POZ domain was mediated by C/EBP-δ. For this, we specifically knocked down C/EBP-δ through the use of small interfering RNA (siRNA) targeting C/EBP-δ in MLE-12-Miz1(∆POZ) cells, then left the cells unstimulated or stimulated then with TNF or LPS (Fig. 5) . In cells treated with control siRNA (with a scrambled sequence), TNF-induced production of proinflammatory cytokines and chemokines was significantly greater in MLE-12-Miz1(∆POZ) cells than in MLE-12-Miz1(WT) cells (Fig. 5b) . Silencing of C/EBP-δ almost completely abolished the enhanced production of proinflammatory cytokines and chemokines in MLE-12-Miz1(∆POZ) cells (Fig. 5b) . We obtained similar results for cells treated with LPS (Fig. 5d) . Thus, suppression of the inflammatory response by Miz1 was dependent on its repression of Cebpd. Fig. 4a ). Indeed, we found association of Miz1 with the proximal region of the Cebpd promoter but with not the control distal region (Supplementary Fig. 4a-c) , consistent with a published report 40 . Under unstimulated conditions, a small amount of Miz1 was already recruited to the Cebpd promoter in MLE-12 cells (Fig. 6a) . That recruitment was further enhanced after 3 h of stimulation with TNF (Fig. 6a) . In contrast, Miz1 was not recruited to the promoter of Cebpb, which encodes C/EBP-β (Fig. 6a) . We obtained similar results for cells treated with LPS ( Supplementary  Fig. 4d ). The recruitment of Miz1 was dependent on the POZ domain, as there was almost no recruitment of Miz1(∆POZ) to the Cebpd promoter (Fig. 6b) .
Miz1 directly represses
To determine whether recruitment of Miz1 to the Cebpd promoter is required for repression of Cebpd transcription, we transfected HEK293 human embryonic kidney cells with a Cebpd luciferase reporter gene along with or without an expression vector encoding wild-type Miz1 or Miz1(∆POZ). Wild-type Miz1 significantly repressed Cebpd promoter activity under resting and TNF-stimulated conditions, but Miz1(∆POZ) did not (Fig. 6c) . We obtained similar results with MLE-12-Miz1(WT) and MLE-12-Miz1(∆POZ) cells (Fig. 6d) . These data demonstrated that Miz1 directly repressed Cebpd transcription under unstimulated and stimulated conditions.
Miz1 represses the Cebpd promoter via histone deacetylase 1
We also determined whether Miz1 repressed Cebpd expression via histone deacetylases (HDACs) 41 . First, we investigated whether HDAC1 regulates Cebpd promoter activity. Silencing of HDAC1 (Supplementary Fig. 4e ) significantly enhanced activity of the Cebpd luciferase reporter gene and Cebpd transcription (Fig. 6e) in TNFtreated MLE-12 cells. Consistent with that, treatment with trichostatin, a specific inhibitor of HDACs, resulted in a greater abundance of acetylated histone on the Cebpd promoter in TNF-treated MLE-12 cells (Fig. 6f) . Thus, HDAC1 was involved in regulating Cebpd promoter activity. 
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To determine whether Miz1 regulated the Cebpd promoter activity via HDAC1, we used chromatin-immunoprecipitation (ChIP) assays. The association between HDAC1 and the Cebpd promoter was readily detectable in resting MLE-12-Miz1(WT) cells and was only modestly lower in MLE-12-Miz1(∆POZ) cells (Fig. 6g) , which suggested that under resting conditions, the association of HDAC1 with the Cebpd promoter did not depend solely on nuclear Miz1. Indeed, p50, which is a member of the NF-κB family but has no transcriptional activity, also bound to the Cebpd promoter, and silencing of p50 resulted in less binding of HDAC1 to the Cebpd promoter under unstimulated conditions (Supplementary Fig. 4f,g ). Thus, both Miz1 and p50 were involved in the binding of HDAC1 to the Cebpd promoter under unstimulated conditions.
Next we determined whether Miz1 recruited HDAC1 to the Cebpd promoter after stimulation with TNF. We found that 2 h after stimulation with TNF, during which time Miz1 constitutively, though weakly, bound to the Cebpd promoter (Fig. 6a) , HDAC1 was released from the Cebpd promoter in both MLE-12-Miz1(WT) and MLE-12-Miz1(∆POZ) cells (Fig. 6g) . That finding suggested that the temporary release of HDAC1, which may have allowed transient transcription of Cebpd (Fig. 4f) , was not regulated by Miz1. Notably, there was less binding of p50 to the Cebpd promoter 1-2 h after stimulation with TNF, whereas the NF-κB subunit RelA was recruited to the promoter (Supplementary Fig. 4f,h) . The replacement of p50 by RelA may have relieved the repression by p50, allowing transient transcription of Cebpd after stimulation with TNF, consistent with a published report 42 . The reason a small amount of Miz1 was retained on the promoter of Cebpd during this time was probably to prevent excessive expression of Cebpd after stimulation with TNF.
In the late phase (3-4 h) of stimulation with TNF, when Miz1 was further recruited to the Cebpd promoter (Fig. 6a) , HDAC1 was recruited again to the Cebpd promoter in MLE-12-Miz1(WT) cells but not in MLE-12-Miz1(∆POZ) cells (Fig. 6g) . This result suggested that Miz1 was required for the re-recruitment of HDAC1 to the Cebpd promoter. Although the abundance of acetylated histone at the Cebpd promoter was greater in both MLE-12-Miz1(WT) and MLE-12-Miz1(∆POZ) cells 2 h after stimulation with TNF (Fig. 6h) , it was significantly lower in MLE-12-Miz1(WT) cells, but not in MLE-12-Miz1(∆POZ) cells, at the late phase of stimulation with TNF (Fig. 6h) . Consistent with that, recruitment of RNA polymerase II to the Cebpd promoter was lower in MLE-12-Miz1(WT) cells, but not in MLE-12-Miz1(∆POZ) cells, 3 h after stimulation with TNF (Supplementary Fig. 4i) . Furthermore, silencing of HDAC1 enhanced Cebpd transcription in MLE-12-Miz1(WT) cells but only had a minimal effect on MLE-12-Miz1(∆POZ) cells (Fig. 6i) . These data suggested that the Miz1 POZ domain was required for TNFinduced re-recruitment of HDAC1 to the Cebpd promoter to silence Cebpd transcription in the late phase of inflammation.
Miz1 controls binding of NF-kB and ATF-3 to the Cebpd promoter
We sought to determine whether loss of the Miz1 POZ domain affected the binding of NF-κB and ATF-3 to the Cebpd promoter. Semiquantitative RT-PCR and immunoblot analysis showed that expression of the NF-κB subunits RelA, RelB, c-Rel, p50 and p52 (Fig. 7a,b) . ChIP analysis showed that binding of Miz1 to the Cebpd promoter was persistent in MLE-12-Miz1(WT) cells but was lower in MLE-12-Miz1(∆POZ) cells (Fig. 7c) , consistent with our data (Fig. 6a) and published reports showing that the POZ domain is essential for the binding of Miz1 to DNA 11, 12, 14 . Binding of RelA to the Cebpd promoter was transient in MLE-12-Miz1(WT) cells but was sustained in MLE-12-Miz1(∆POZ) cells (Fig. 7d) . That result suggested that Miz1 may have negatively regulated the binding of RelA, probably through HDAC1-mediated histone deacetylation (Fig. 6) , as acetylation is a prerequisite for the recruitment of NF-κB to its target promoters 43 . In contrast, TNF-induced binding of ATF-3 to the Cebpd promoter was delayed and diminished in MLE-12-Miz1(∆POZ) cells (Fig. 7e) , which suggested that Miz1 may have positively regulated the binding of ATF-3 to the Cebpd promoter, probably through control of transcription of the gene encoding ATF-3 (Fig. 7a,b) . These data demonstrated that binding of RelA, Miz1 and ATF-3 to the Cebpd promoter was temporally coordinated and that Miz1 regulated the binding of RelA and ATF-3 to the Cebpd promoter.
Repression of Cebpd requires phosphorylation of Miz1
To determine how the Miz1-mediated transcriptional repression of Cebpd was regulated by TNF, we analyzed the post-translational modifications of Miz1 after stimulation with TNF. Tandem mass spectrometry showed that Miz1 was phosphorylated at a unique site, Ser178 (located between the POZ domain and the first zinc finger), in lung epithelial cells 1 h after stimulation with TNF (Fig. 8a) .
Although ectopic expression of wild-type Miz1 in MLE-12 cells in which endogenous Miz1 was stably knocked down by Miz1-specific shRNA suppressed TNF-induced Cebpd luciferase reporter gene activity, expression of a Miz1 mutant that cannot be phosphorylated (Miz1(S178A); with replacement of the serine at position 178 with alanine) did not do so (Fig. 8b) .
To further determine the function of the phosphorylation of Miz1 Ser178, we established MLE-12 cells in which endogenous Miz1 expression was stably knocked down by Miz1-specific shRNA 
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A r t i c l e s (Supplementary Fig. 2c) , along with transfection for stable expression of Miz1(S178A) (containing silent mutations in the sequence encoding it that make it resistant to Miz1-specific shRNA) similar to that of wildtype Miz1 in MLE-12-Miz1(WT) cells (MLE-12-Miz1(S178A) cells; Fig. 8c, top) . Analysis by real-time RT-PCR and cytometric bead array showed that TNF-induced Cebpd transcription and IL-6 production were significantly greater in MLE-12-Miz1(S178A) cells than in MLE-12-Miz1(WT) cells (Fig. 8c, bottom) . The S178A substitution had no detectable effect on the binding of Miz1 to the Cebpd promoter under unstimulated conditions but almost completely abolished recruitment of Miz1 to the Cebpd promoter after stimulation with TNF (Fig. 8d) . Consistent with that, there was significantly less re-recruitment of HDAC1 to the Cebpd promoter in MLE-12-Miz1(S178A) cells than in MLE-12-Miz1(WT) cells 3-4 h after stimulation with TNF (Fig. 8e) . TNF-induced activation of MAP kinases (Jnk, p38 and Erk) and of IKK was similar in MLE-12-Miz1(WT) and MLE-12-Miz1(S178A) cells (Supplementary Fig. 5 ), which suggested that phosphorylation of Miz1 Ser178 was not involved in regulating the cytoplasmic activity of Miz1. Together these results indicated that TNF-induced phosphorylation of Miz1 Ser178 was a prerequisite step for the TNF-induced recruitment of Miz1 to the Cebpd promoter for repression of Cebpd transcription through further recruitment of HDAC1, which inhibited the production of cytokines such as IL-6.
DISCUSSION
Inflammation is tightly controlled by a complex regulatory network 11, 16 . Although the mechanisms underlying the initiation and amplification of the inflammatory response have been studied extensively, how the inflammatory response is temporally resolved is not completely understood. In this report, we found that the transcription factor Miz1 was a key regulator in constraining LPS-induced inflammatory response through histone deacetylation-mediated transcriptional repression of Cebpd in a pathophysiological setting.
C/EBP-δ is responsible for LPS-induced persistent inflammation, and its expression is positively regulated by NF-κB but negatively regulated by ATF-3 (ref. 9) . Genetic disruption of the Miz1 POZ domain resulted in more transcription of Cebpd and other genes targeted by LPS, such as Il6. Thus, nuclear Miz1 is another negative regulator of C/EBP-δ. Miz1 also regulated basal C/EBP-δ expression. In cells and mice deficient in the Miz1 POZ domain, C/EBP-δ expression was already upregulated under unstimulated conditions, even though there was no detectably higher expression of proinflammatory cytokines or inflammation. This suggests that upregulation of C/EBP-δ alone is not sufficient to initiate inflammation. However, the upregulated expression of C/EBP-δ may promote the initiation of inflammation when cells are stimulated by inflammatory signals, probably through its cooperation with NF-κB 5 . Indeed, loss of the Miz1 POZ domain accelerated the expression of proinflammatory cytokines. Thus, Miz1 regulates LPS-induced inflammation through the repression of both basal and stimulated C/EBP-δ expression.
ATF-3 affects only the strength, not the duration, of LPS-induced transcription of Cebpd and other LPS-target genes 9 ; however, we found that loss of the Miz1 POZ domain resulted in sustained augmentation of Cebpd transcription, which led to a persistent inflammatory response in the LPS model. Consistent with that, Miz1 also suppressed the inflammatory response in mice with P. aeruginosa pneumonia. Thus, nuclear Miz1 serves a critical role in terminating LPS-induced inflammation and functions as a 'guardian' that constrains TLR4-mediated hyperinflammation, thereby preventing acute lung injury and diminishing mortality in LPS-treated mice.
Our study has identified Miz1 as an additional component of the NF-κB-ATF-3-C/EBP-δ transcription-regulatory circuit. Nuclear Miz1 not only directly repressed Cebpd transcription but also affected recruitment of the NF-κB subunit RelA, the initiator of the transcriptional regulatory circuit 11 , to the Cebpd promoter. Loss of the Miz1 POZ domain resulted in less re-recruitment of HDAC1 and a lower abundance of deacetylated histone at the Cebpd promoter. This may have been the reason for the sustained binding of RelA to the Cebpd promoter in Miz1(∆POZ) cells, as histone acetylation usually precedes the binding of RelA to the promoters of its target genes 43 . The persistent binding of RelA to the Cebpd promoter in the absence of the Miz1 POZ domain after stimulation with TNF occurred long after resynthesis of the NF-κB inhibitor IκBα, which suggested that newly synthesized IκBα was not sufficient to promote removal of RelA from the promoters of its target genes, consistent with a published report 43 . However, Miz1 controlled ATF-3 expression and consequently the amount of ATF-3 that bound to the Cebpd promoter. Thus, Miz1 terminated the expression of genes encoding inflammatory molecules in the late phase of the inflammatory responses membrane mediated by TLR4 and the TNF membrane receptor 1 complex I, and it did so by at least two mechanisms. First, Miz1 directly bound to the Cebpd promoter and recruited HDAC1, thereby interfering with the binding of RelA and repressing Cebpd transcription. Second, Miz1 upregulated ATF-3 expression, thereby indirectly repressing Cebpd transcription 11 . Additional studies are needed to determine how Miz1 regulates ATF-3 expression.
Phosphorylation of Miz1 was involved in the suppression of TNF-induced inflammation. After stimulation with TNF, Miz1 was phosphorylated at a previously unidentified site, Ser178, and such phosphorylation was required for Miz1 to bind to the Cebpd promoter and recruit HDAC1 during the late phase of inflammation to repress Cebpd transcription and IL-6 production. Thus, phosphorylation of Ser178 may control the transcription-repression activity of Miz1 in TNF-induced inflammation. One possible mechanism for this is that phosphorylation may enable Miz1 to recruit additional factors to stabilize its binding to the Cebpd promoter. Further studies are needed to test this hypothesis and to determine which protein kinase(s) phosphorylate(s) Miz1 Ser178 in response to stimulation with TNF.
Miz1 serves as a dual checkpoint in the regulation of LPS-induced inflammation. Cytoplasmic Miz1 suppresses LPS-or TNF-induced production of proinflammatory cytokines through inhibition of Jnk activation mediated by the adaptor TRAF2, independently of its transcriptional activity [16] [17] [18] . Such inhibition is rapidly released after the stimulation (<15 min) when TRAF2-associated Miz1 is ubiquitinated by the E3 ligase Mule and is subsequently degraded by the 26S proteasome, which suggests that cytoplasmic Miz1 is involved in restraining the onset rate of LPS-or TNF-induced inflammatory responses 27, 29 . Our data have shown that nuclear Miz1 suppressed LPS-induced persistent inflammation by transcriptional repression of Cebpd, which encodes the amplifier that controls the expression of a large number of genes targeted by LPS, thereby constraining the inflammatory response. Thus, Miz1 may function as a dual checkpoint that temporally and spatially modulates the LPS-induced inflammatory response, thereby preventing tissue damage and organ failure in the host.
METHODS
Methods and any associated references are available in the online version of the paper. 
